Earnings surprises may fuel Celgene, Regeneron's soaring stock prices
This article was originally published in Scrip
Executive Summary
Celgene and Regeneron Pharmaceuticals execs can boast that they have two of the best-performing biotech stocks in the US. Shares of Regeneron are up almost 60% this year, while Celgene jumped more than 70%.